Finally, FOXA1, a transcription factor required for sweat secretion, previously shown to be downregulated in HS lesional skin and upregulated in wound-healing skin, was significantly upregulated following 8 weeks of treatment with 30 mg povorcitinib QD. This evidence concerns the gene FOXA1 and histiocytic sarcoma.